Comparing DS Healthcare Group (DSKX) & Nautilus (NLS)

Nautilus (NYSE: NLS) and DS Healthcare Group (OTCMKTS:DSKX) are both small-cap non-cyclical consumer goods & services companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation.

Profitability

This table compares Nautilus and DS Healthcare Group’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Nautilus 7.28% 18.54% 9.76%
DS Healthcare Group -62.31% -1,304.25% -117.85%

Analyst Recommendations

This is a summary of current ratings and recommmendations for Nautilus and DS Healthcare Group, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nautilus 0 3 4 0 2.57
DS Healthcare Group 0 0 0 0 N/A

Nautilus currently has a consensus price target of $18.96, suggesting a potential upside of 43.13%. Given Nautilus’ higher possible upside, research analysts clearly believe Nautilus is more favorable than DS Healthcare Group.

Institutional and Insider Ownership

97.9% of Nautilus shares are owned by institutional investors. Comparatively, 0.0% of DS Healthcare Group shares are owned by institutional investors. 3.7% of Nautilus shares are owned by company insiders. Comparatively, 19.4% of DS Healthcare Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Valuation and Earnings

This table compares Nautilus and DS Healthcare Group’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Nautilus $406.04 million 1.00 $34.17 million $1.00 13.25
DS Healthcare Group $12.95 million 0.01 -$6.93 million ($0.28) -0.02

Nautilus has higher revenue and earnings than DS Healthcare Group. DS Healthcare Group is trading at a lower price-to-earnings ratio than Nautilus, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Nautilus has a beta of 2.12, meaning that its share price is 112% more volatile than the S&P 500. Comparatively, DS Healthcare Group has a beta of -0.16, meaning that its share price is 116% less volatile than the S&P 500.

Summary

Nautilus beats DS Healthcare Group on 12 of the 13 factors compared between the two stocks.

Nautilus Company Profile

Nautilus, Inc. is a consumer fitness products company. The Company operates through two segments: Direct and Retail. Its principal business activities include designing, developing, sourcing and marketing of cardio and strength fitness products and related accessories for consumer use, primarily in the United States and Canada, but also in international markets outside North America. The Direct business offers products directly to consumers through television advertising, catalogs and the Internet. In its Direct business, the Company markets and sells its products, principally Bowflex cardio and strength products, directly to consumers. The Retail business offers its products through a network of independent retail companies and specialty retailers with stores and Websites located in the United States and internationally. In its Retail business, the Company markets and sells a line of consumer fitness equipment under the Nautilus, Octane Fitness, Schwinn, Universal and Bowflex brands.

DS Healthcare Group Company Profile

DS Healthcare Group, Inc., doing business as DS Laboratories, is a personal care, product development and marketing company. The Company develops and markets branded personal care products that address thinning hair conditions, skin care and other personal care needs. It develops technologies and products for hair care and personal care needs. Its technologies include Liposome Technology, which acts as a carrier agent, and is designed to enhance the act ion of the active ingredients in its products, and Nanosome Technology, which acts as a delivery vehicle, and is designed to infuse active compounds into targeted cells. The Company products are primarily sold under its DS Laboratories brand. It also sells certain products under its Polaris Labs and Sigma Skin brands. It markets and sells these products through salons, spas, department stores, specialty retailers and distributors. The Company offers products under three product categories: Hair Care, Skin Care and Personal Care.

Receive News & Ratings for Nautilus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nautilus and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply